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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
 
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
28.05.2020 Associations of 
hypertension 
with the 
severity and 
fatality of 
SARS-CoV-2 
infection: a 
meta-analysis 
Epidemiology & 
Infection | 
Meta-analysis 
 Hypertensive patients were at a 
3.48-fold higher risk of dying 
from COVID-19 (95% CI: 1.72-
7.08) 
 Pooled ORs of COVID-19 
fatality for hypertension vs non-
hypertension was 6.43 (95% 
CI: 3.40-12.17) and 2.66 (95% 
CI: 1.27-5.57) in age <50y and 
>=50y patients respectively 
 Hypertension could significantly 
increase the risk of severity and 
fatality of SARS-CoVd-2 
infection 
26.05.2020 Do the clinical 
management 
guidelines for 
Covid-19 in 
African 
countries 
Bull WHO | 
Review 
 This review identified and 
critically appraised the palliative 
care recommendations within 
COVID-19 case management 
guidelines in Africa 
 Governments and policymakers 
in Africa must prioritise 
2 
reflect the 
African quality 
palliative care 
standards? A 
rapid review 
palliative care within case 
management guidelines to 
ensure patients with COVID-19 
have access 
 22.05.2020 Ventilation 
techniques and 
risk for 
transmission of 
coronavirus 
disease, 
including 
COVID-19: A 
living 
systematic 
review of 
multiple 
streams of 
evidence 
Annals of 
Internal 
Medicine | 
Review 
 A review of multiple streams of 
evidence regarding the benefits 
and harms of ventilation 
techniques for coronavirus 
infections, including that 
causing COVID-19 
 A limitation was that direct 
studies in COVDI-19 are limited 
and poorly reported 
 Indirect and low-certainty 
evidence suggests that use of 
non-invasive ventilation, similar 
to invasive mechanical 
ventilation, probably reduces 
mortality but may increase the 
risk for transmission of COVID-
19 to HCWs 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
28.05.2020 Asymptomatic 
transmission 
during the 
COVID-19 
pandemic and 
implications for 
public health 
strategies 
Clinical 
Infectious 
Diseases | 
Narrative 
review 
 
 This summary of evidence 
demonstrates the transmission 
potential of SARS-CoV-2 from 
asymptomatic and pre-symptomatic 
individuals 
 Authors urge reassessment of 
public health strategies relying 
solely on ‘symptom’ onset for 
infection identification 
 Extensive universal 
testing  irrespective of symptoms 
should be considered with priority 
given to those with high frequency 
exposure to positive patients 
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Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
27.05.2020 Small droplet 
aerosols in 
poorly 
ventilated 
spaces and 
SARS-CoV-2 
transmission 
The Lancet 
Respiratory 
Medicine | 
Comment 
 A study to better understand 
the spreading of respiratory 
droplets and possible 
preventive measures  
 Although only healthy 
volunteers were studied, data 
on droplet size distribution and 
persistence has implications on 
requirements to use face 
masks to prevent virus 
transmission 
 Better ventilation of spaces 
substantially reduces the 
airborne time of respiratory 
droplets relevant in that 
typically poorly ventilated and 
populated spaces have 
reported sites of viral 
transmission despite preventive 
physical distancing 
 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
 27.05.2020 Hydroxychloroquine 
or chloroquine for 
treatment or 
prophylaxis of 
COVID-19: A living 
systematic review 
Annals of 
Internal 
Medicine | 
Review 
 This review summaries 
evidence about the benefits 
and harms of 
hydroxychloroquine or 
chloroquine for the 
treatment or prophylaxis of 
COVID-19 
 No studies evaluated 
prophylaxis 
 Evidence was conflicting 
and insufficient regarding 
the effect of 
hydroxychloroquine on 
4 
such outcomes as all-
cause mortality, 
progression to severe 
diseases, clinical 
symptoms, and upper 
respiratory virologic 
clearance with antigen 
testing 
 Evidence on the benefits 
and harms of using 
hydroxychloroquine or 
chloroquine to treat 
COVID-19 is very weak 
and conflicting 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
28.05.2020 A vulnerability 
index for 
COVID-19: 
spatial 
analysis to 
inform 
equitable 
response in 
Kenya 
medRxiv 
|preprint (not 
peer reviewed) 
 3 vulnerability indices were used to 
identify areas and people who 
require greater support in the public 
health pandemic response to C19 in 
Kenya 
 The combined index of social and 
epidemiological vulnerabilities 
shows that on average 15% (7 
million) of Kenyans live in the most 
vulnerable sub-counties mainly 
located in the central and south-
eastern parts of Kenya 
 The heterogeneous nature of the 
vulnerability highlights the need to 
address social determinants of 
health disparities, strengthen the 
health system and establish 
programmes to buffer against the 
impact of C19 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
June 2020 Obstacles to COVID-19 control 
in east Africa 
The Lancet Infectious 
Diseases | Newsdesk 
Esther Nakkazi 
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June 2020 A call for a global COVID-19 
neuro research coalition 
The Lancet Neurology | 
Correspondence 
Andrew Sylvia 
Winkler et al. 
28.05.2020 Covid-19: WHO halts 
hydroxychloroquine trial to 
review links with increased 
mortality risk 
BMJ | News  
28.05.2020 COVID-19’s collateral damage 
could devastate low- and middle-
income countries 
GAVI | Blog  
28.05.2020 How Mauritius’ unique political 
culture helped it beat COVID-19 
African Arguments | 
Blog 
Myriam Blin 
Jess Auerbach 
27.05.2020 Pandemic preparedness: 
developing vaccines and 
therapeutic antibodies for 
COVID-19 
Cell |Perspective Gregory D. 
Sempowski 
Kevin O. 
Saunders 
Priyamvada 
Acharya 
Kevin J. Wiehe 
Barton F. Haynes 
27.05.2020 The COVID-19 MS Coalition – 
accelerating diagnostics, 
prognostics, and treatment 
The Lancet | 
Correspondence 
Weston Struwe 
Edward Emmott 
Melanie Bailey 
Michal Sharon 
Andrea Sinz 
Fernando  J 
Corrales et al. 
27.05.2020 Ratio, rate, or risk? The Lancet Infectious 
Diseases | 
Correspondence 
Srinivas Mantha 
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27.05.2020 Hydroxychloroquine: balancing 
the needs of LMICs during the 
COVID-19 pandemic 
The Lancet 
Rheumatology | 
Correspondence 
Soumya Banerjee 
27.05.2020 Reducing transmission of SARS-
CoV-2 
Science | Perspective Kimberly A. 
Prather 
Chia C. Wang 
Robert T. 
Schooley 
27.05.2020 Tracking the gender impact of 
COVID-19 
CGD | Blog Mayra Buvinic 
Lorenz Noe 
Eric Swanson 
27.05.2020 Introducing the COVID-19 multi-
model comparison collaboration 
CGD | Blog Kalipso Chalkidou 
Marelize Gorgens 
Raymond 
Hutubessy 
Yot 
Teerawattananon 
David Wilson 
27.05.2020 Disease forecasting during the 
COVID-19 pandemic: have we 
learned from previous outbreaks 
CGD | Blog Hiral Anil Shah 
Kalipso Chalkidou 
26.05.2020 A tool to estimate the et health 
impact of COVID-19 policies 
CGD | Blog Damian Walker 
Y-Ling Chi 
Florian Poli 
Kalipso Chalkidou 
26.05.2020 Adverse consequences of 
rushing a SARS-CoV-2 vaccine: 
implications for public trust 
JAMA | Viewpoint Brit Trogen 
David Oshinsky 
Arthur Caplan 
7 
22.05.2020 Cloth masks may prevent 
transmission of COVID-19: an 
evidence-based, risk-based 
approach 
Annals of Internal 
Medicine | Ideas and 
Opinions 
Catherine M. 
Clase 
Edouard L. Fu 
Meera Joseph et 
al. 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
 COVID-
19 
Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
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Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
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C19 Resource Hubs 
Global  Region
al & 
Country 
Academi
c journals 
& 
Publisher
s 
Institutes/Centres/Funders/O
ther 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicatio
n 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
Cambridg
e 
Universit
y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academ
y of 
Science
s 
Cochrane  Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Network 
Elsevier CMMID Repository     
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UNOCHA OCHA 
Souther
n and 
Eastern 
Africa 
COVID-
19 
Digest 
JAMA 
Network 
Norwegian Institute of Public 
Health 
    
UNHCR   The 
Lancet 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints
) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources and 
Analyses of C19 Impact 
    
World Bank   Science  Prevent Epidemics      
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David 
Nabarro 
  SSRN 
(Preprints
)  
      
Reliefweb   Wiley       
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Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
May 28 
09:30 am to 
11:00 am 
EDT 
Virtual Event - No 
backsliding: How can 
we re-orient food 
systems and health 
systems to protect 
nutrition and healthy 
diets in the context of 
COVID-19? 
Virtual event 1.5 hours IFPRI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
12 
04.06.2020 
12pm ET 
CGD Conversations 
on COVID-19 and 
Development: John 
Nkengasong 
Event   CGD 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
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Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
14 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
